Memorial Şişli Hospital
Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.
Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.
Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.
Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.
Specialists in Turkey treat IgG4-Related Disease using international protocols focussed on rapid remission and relapse prevention. The primary approach involves high-dose glucocorticoids, while refractory cases receive B-cell depletion therapy. Major Istanbul centres like Memorial Şişli Hospital use multidisciplinary teams to manage multi-organ involvement.
Bookimed Expert Insight: Turkish oncology and transplant centres provide a distinct advantage for complex IgG4-RD cases. This is especially true when the liver or pancreas is affected. Facilities like Medical Park Antalya report high success in organ-related procedures. Prof. Sezer Sağlam focusses on gastrointestinal oncology and immunotherapy. His presence ensures patients receive precision treatments like targeted systemic therapy. These are used when standard immunosuppression requires expert adjustment.
Patient Consensus: Patients note that prednisone provides fast relief from flares. However, many require rituximab or azathioprine to maintain remission. Those with pancreatic involvement emphasise that ongoing specialist monitoring in Turkey is vital. It helps manage potential digestive issues or diabetes.
Turkish tertiary hospitals manage complex IgG4-related disease. They do this using multidisciplinary teams of rheumatologists, gastroenterologists, and pathologists. Clinics employ JCI-accredited protocols to differentiate fibrotic masses from malignancies. Treatment involves high-dose corticosteroids. It also includes biliary stenting via ERCP. For refractory cases, biological therapies like rituximab are used.
Bookimed Expert Insight: Turkish oncology and transplant hubs like Memorial Şişli Hospital treat thousands of complex cases annually. This high volume is critical for IgG4-RD, as its features mimic rare tumours. Expert pathologists, such as Dr Huseyin Baloglu, use precision molecular diagnostics. This confirms the inflammatory nature of the disease first. It helps patients avoid unnecessary major surgeries.
Patient Consensus: Patients emphasise that surgery provides immediate relief for blocked ureters or bile ducts. However, it is not a cure. Durable success in Turkey relies on a combined approach. First, procedural decompression is performed. Then, long-term immunosuppressive medication and regular imaging prevent the fibrosis from returning.
Turkish rheumatology and pathology departments lead the management of IgG4-Related Disease. Top JCI-accredited hospitals provide multi-organ coordination. These include Memorial Şişli, Anadolu Medical Center, and Hisar Hospital Intercontinental. These centres use digital PET/CT and immunohistochemistry to distinguish this inflammatory condition from malignancy.
Bookimed Expert Insight: Turkish private centres often bypass the long wait times seen in public systems. Data show that clinics like Memorial Şişli are best equipped for multi-organ coordination. These clinics serve patients from 167 countries. This is vital for IgG4-RD. Patients frequently require simultaneous input from rheumatology, gastroenterology, and radiology to prevent organ scarring.
Patient Consensus: Patients note that Turkey's international hospitals offer same-day appointments. This is essential for managing sudden flares. They recommend bringing all prior biopsy slides and imaging. This ensures specialists can quickly decide between starting steroids or moving to rituximab therapy.
Diagnostic workups for IgG4-related disease in Turkey typically take 3 to 7 working days. Major Istanbul centres provide rapid access to PET/CT, MRI, and targeted biopsies. Specialist rheumatologists or immunologists can often initiate corticosteroid induction therapy within one week of arrival.
Bookimed Expert Insight: While initial consultations happen fast, pathology is the primary bottleneck. Patients should choose university hospitals like Medipol Mega or İstinye University Liv Hospital. These centres have on-site molecular pathology labs and specialists like Dr Huseyin Baloglu. Having pathology experts in-house avoids the delays of sending tissue samples to external labs.
Patient Consensus: Patients note that a final biopsy takes time. However, doctors often start a prednisone trial immediately. This helps prevent organ damage while the multidisciplinary team coordinates specialist input in Turkey.